Ignite Creation Date:
2024-05-06 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06188611
Status:
COMPLETED
Last Update Posted:
2024-01-03
First Post:
2023-12-13
Brief Title:
A Phase IV Study of Huazhi Rougan Granule
Sponsor:
Shandong New Time Pharmaceutical Co LTD
Organization:
Shandong New Time Pharmaceutical Co LTD
Study Overview
Official Title:
A Placebo Control Randomized Double-blind Multicenter Phase IV Study to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver Damp-heat Obstruction Syndrome Shi-Re-Zhong-Zu Zheng
Status:
COMPLETED
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Placebo control Randomized Double-blind Multicenter Phase IV study to investigate the efficacy and safety of Huazhi Rougan granule in the treatment of non-alcoholic simple fatty liver damp-heat obstruction syndrome Shi-Re-Zhong-Zu Zheng
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None